Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Synthesis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel chlorination method for Clopidogrel intermediate. High yield, cost-effective, reliable supply chain for pharmaceutical manufacturing.
Patent CN100385007C details a microbial method for (R)-mandelic acid using Brevibacterium flavum, offering high optical purity and scalable biocatalysis for pharma intermediates.
Novel patent CN105777584B offers low-cost alanine derivative synthesis route. Enhances supply chain reliability and cost efficiency for pharmaceutical intermediates manufacturing globally.
Discover the novel chiral reduction method for L-phenylephrine hydrochloride production. This patent-based analysis highlights cost-effective manufacturing and high-purity supply chain solutions.
Patent CN101696185A details a high-yield synthesis of 6-nitro-S-(-)-indoline-2-carboxylic acid from L-phenylalanine, offering cost-effective chiral intermediate solutions.
Patent CN101696185A details a high-yield chiral synthesis route. We offer reliable supply and cost reduction in pharmaceutical intermediates manufacturing.
Novel eight-step synthesis from L-asparagine avoids chiral resolution, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN102399139B details a scalable resolution method for Shikonin and Alkannin. Achieve >99% ee with cost-effective raw materials for API manufacturing.
Patent CN109553610A details a novel six-step synthesis for emtricitabine isomers offering high purity and scalable manufacturing processes for global supply chains.
Advanced synthesis of Saquinavir intermediate via L-Phenylalanine. High yield (75%), >99% optical purity. Cost-effective route for API manufacturing.
Novel synthesis route for chiral pyrrolo-pyridine intermediates offers high purity and scalability. Enhances supply chain reliability and reduces manufacturing complexity for global buyers.
Patent CN105820113A details a robust chiral resolution method for Crizotinib intermediates. This process ensures high purity, operational simplicity, and substantial cost reduction in pharmaceutical manufacturing.
Patent CN111393329A details a high-yield synthesis of BDH, a key ritonavir intermediate, utilizing stereoselective reduction for cost-effective manufacturing.
Patent CN115724792A reveals a streamlined ammonolysis route for Edoxaban intermediates, offering significant cost reduction and scalable manufacturing for global supply chains.
Novel patent CN108658797A offers cost-effective Mirabegron intermediate synthesis with high purity and scalable supply chain solutions for global pharmaceutical manufacturing.
Patent CN115197115A details a novel chiral synthesis route offering high optical purity and scalable manufacturing for pharmaceutical intermediates and cost reduction.
Patent CN102603603B reveals high-purity (S)-oxiracetam synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Advanced synthesis of Barnidipine Hydrochloride via chiral resolution. High purity, scalable route for API manufacturing. Cost-effective solution for hypertension drugs.
Patent CN107353221B reveals Pd-catalyzed chiral amide synthesis offering high conversion rates and supply chain stability for global pharmaceutical intermediates manufacturing.
Advanced chiral synthesis of pregabalin via dibenzylamine intermediates. Reduces genotoxic risks and improves scalability for reliable API manufacturing supply chains.